APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonalcoholic Steatohepatitis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nonalcoholic Steatohepatitis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchNonalcoholic Steatohepatitis Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonalcoholic Steatohepatitis Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Nonalcoholic Steatohepatitis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonalcoholic Steatohepatitis Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonalcoholic Steatohepatitis Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Nonalcoholic Steatohepatitis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nonalcoholic Steatohepatitis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nonalcoholic Steatohepatitis Treatment include Arena Pharmaceuticals, Arisaph Pharmaceuticals, Cempra Pharmaceuticals, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead, Novo Nordisk and Vivus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nonalcoholic Steatohepatitis Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nonalcoholic Steatohepatitis Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nonalcoholic Steatohepatitis Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nonalcoholic Steatohepatitis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Nonalcoholic Steatohepatitis Treatment Segment by Company

Arena Pharmaceuticals

Arisaph Pharmaceuticals

Cempra Pharmaceuticals

Galectin Therapeutics

Galmed Pharmaceuticals

Genfit

Gilead

Novo Nordisk

Vivus

AstraZeneca

GSK

Roche

Nonalcoholic Steatohepatitis Treatment Segment by Type

Solid

Liquid

Nonalcoholic Steatohepatitis Treatment Segment by Application

Drug Store

Hospital

Hospital Pharmacy

Mail Order Pharmacy

Diagnostic Center

Specialized Clinic

Nonalcoholic Steatohepatitis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonalcoholic Steatohepatitis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonalcoholic Steatohepatitis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonalcoholic Steatohepatitis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nonalcoholic Steatohepatitis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nonalcoholic Steatohepatitis Treatment industry.

Chapter 3: Detailed analysis of Nonalcoholic Steatohepatitis Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nonalcoholic Steatohepatitis Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Solid Table 3. Key Players of Liquid Table 4. Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Drug Store Table 6. Key Players of Hospital Table 7. Key Players of Hospital Pharmacy Table 8. Key Players of Mail Order Pharmacy Table 9. Key Players of Diagnostic Center Table 10. Key Players of Specialized Clinic Table 11. Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region (2021-2026) Table 14. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region (2027-2032) Table 16. Nonalcoholic Steatohepatitis Treatment Industry Trends Table 17. Nonalcoholic Steatohepatitis Treatment Industry Drivers Table 18. Nonalcoholic Steatohepatitis Treatment Industry Opportunities and Challenges Table 19. Nonalcoholic Steatohepatitis Treatment Industry Restraints Table 20. Global Nonalcoholic Steatohepatitis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2021-2026) Table 22. Global Nonalcoholic Steatohepatitis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Nonalcoholic Steatohepatitis Treatment Key Company Head Office and Area Served Table 24. Global Nonalcoholic Steatohepatitis Treatment Company, Product Type & Application Table 25. Global Nonalcoholic Steatohepatitis Treatment Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2027-2032) Table 33. Global Nonalcoholic Steatohepatitis Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2021-2026) Table 37. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2027-2032) Table 38. Arena Pharmaceuticals Company Information Table 39. Arena Pharmaceuticals Business Overview Table 40. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 42. Arena Pharmaceuticals Recent Development Table 43. Arisaph Pharmaceuticals Company Information Table 44. Arisaph Pharmaceuticals Business Overview Table 45. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 47. Arisaph Pharmaceuticals Recent Development Table 48. Cempra Pharmaceuticals Company Information Table 49. Cempra Pharmaceuticals Business Overview Table 50. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 52. Cempra Pharmaceuticals Recent Development Table 53. Galectin Therapeutics Company Information Table 54. Galectin Therapeutics Business Overview Table 55. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 57. Galectin Therapeutics Recent Development Table 58. Galmed Pharmaceuticals Company Information Table 59. Galmed Pharmaceuticals Business Overview Table 60. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 62. Galmed Pharmaceuticals Recent Development Table 63. Genfit Company Information Table 64. Genfit Business Overview Table 65. Genfit Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Genfit Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 67. Genfit Recent Development Table 68. Gilead Company Information Table 69. Gilead Business Overview Table 70. Gilead Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Gilead Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 72. Gilead Recent Development Table 73. Novo Nordisk Company Information Table 74. Novo Nordisk Business Overview Table 75. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 77. Novo Nordisk Recent Development Table 78. Vivus Company Information Table 79. Vivus Business Overview Table 80. Vivus Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Vivus Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 82. Vivus Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 87. AstraZeneca Recent Development Table 88. GSK Company Information Table 89. GSK Business Overview Table 90. GSK Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. GSK Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 92. GSK Recent Development Table 93. Roche Company Information Table 94. Roche Business Overview Table 95. Roche Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Roche Nonalcoholic Steatohepatitis Treatment Product Portfolio Table 97. Roche Recent Development Table 98. North America Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 99. North America Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 100. North America Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 101. North America Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 102. North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) Table 104. North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032) Table 105. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 106. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 107. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 108. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 109. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) Table 111. Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032) Table 112. China Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 113. China Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 114. China Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 115. China Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 117. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 118. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 119. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 120. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) Table 122. Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032) Table 123. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 124. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 125. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026) Table 129. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032) Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Nonalcoholic Steatohepatitis Treatment Product Image Figure 2. Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Share by Type: 2025 VS 2032 Figure 4. Solid Image Figure 5. Liquid Image Figure 6. Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Nonalcoholic Steatohepatitis Treatment Market Share by Application: 2025 VS 2032 Figure 8. Drug Store Image Figure 9. Hospital Image Figure 10. Hospital Pharmacy Image Figure 11. Mail Order Pharmacy Image Figure 12. Diagnostic Center Image Figure 13. Specialized Clinic Image Figure 14. Global Nonalcoholic Steatohepatitis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 16. Global Nonalcoholic Steatohepatitis Treatment Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Nonalcoholic Steatohepatitis Treatment Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 26. North America Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032) Figure 27. North America Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032) Figure 28. North America Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 29. United States Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Canada Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032) Figure 34. Europe Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032) Figure 35. Europe Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 36. Germany Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 37. France Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Italy Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Russia Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032) Figure 44. China Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032) Figure 45. Asia Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 46. Asia Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032) Figure 47. Asia Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032) Figure 48. Asia Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 49. Japan Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 53. India Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Australia Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032) Figure 59. Brazil Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 64. UAE Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Chile Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Solid
  • Liquid
Applications
  • Drug Store
  • Hospital
  • Hospital Pharmacy
  • Mail Order Pharmacy
  • Diagnostic Center
  • Specialized Clinic
Companies covered
  • Arena Pharmaceuticals
  • Arisaph Pharmaceuticals
  • Cempra Pharmaceuticals
  • Galectin Therapeutics
  • Galmed Pharmaceuticals
  • Genfit
  • Gilead
  • Novo Nordisk
  • Vivus
  • AstraZeneca
  • GSK
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Solid
  5. 1.2.3 Liquid
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Drug Store
  9. 1.3.3 Hospital
  10. 1.3.4 Hospital Pharmacy
  11. 1.3.5 Mail Order Pharmacy
  12. 1.3.6 Diagnostic Center
  13. 1.3.7 Specialized Clinic
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Nonalcoholic Steatohepatitis Treatment Growth Trends by Region
  16. 1.5.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Nonalcoholic Steatohepatitis Treatment Market Size by Region (2021-2026)
  18. 1.5.3 Nonalcoholic Steatohepatitis Treatment Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Nonalcoholic Steatohepatitis Treatment Market Dynamics
  1. 2.1 Nonalcoholic Steatohepatitis Treatment Industry Trends
  2. 2.2 Nonalcoholic Steatohepatitis Treatment Industry Drivers
  3. 2.3 Nonalcoholic Steatohepatitis Treatment Industry Opportunities and Challenges
  4. 2.4 Nonalcoholic Steatohepatitis Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Nonalcoholic Steatohepatitis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nonalcoholic Steatohepatitis Treatment Key Company Head office and Area Served
  4. 3.4 Global Nonalcoholic Steatohepatitis Treatment Company, Product Type & Application
  5. 3.5 Global Nonalcoholic Steatohepatitis Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nonalcoholic Steatohepatitis Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nonalcoholic Steatohepatitis Treatment Tier 1, Tier 2, and Tier 3
4 Nonalcoholic Steatohepatitis Treatment Market by Type
  1. 4.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Nonalcoholic Steatohepatitis Treatment Market Size Share by Type (2021-2032)
5 Nonalcoholic Steatohepatitis Treatment Market by Application
  1. 5.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Nonalcoholic Steatohepatitis Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Arena Pharmaceuticals
  2. 6.1.1 Arena Pharmaceuticals Company Information
  3. 6.1.2 Arena Pharmaceuticals Business Overview
  4. 6.1.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  6. 6.1.5 Arena Pharmaceuticals Recent Developments
  7. 6.2 Arisaph Pharmaceuticals
  8. 6.2.1 Arisaph Pharmaceuticals Company Information
  9. 6.2.2 Arisaph Pharmaceuticals Business Overview
  10. 6.2.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  12. 6.2.5 Arisaph Pharmaceuticals Recent Developments
  13. 6.3 Cempra Pharmaceuticals
  14. 6.3.1 Cempra Pharmaceuticals Company Information
  15. 6.3.2 Cempra Pharmaceuticals Business Overview
  16. 6.3.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  18. 6.3.5 Cempra Pharmaceuticals Recent Developments
  19. 6.4 Galectin Therapeutics
  20. 6.4.1 Galectin Therapeutics Company Information
  21. 6.4.2 Galectin Therapeutics Business Overview
  22. 6.4.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Portfolio
  24. 6.4.5 Galectin Therapeutics Recent Developments
  25. 6.5 Galmed Pharmaceuticals
  26. 6.5.1 Galmed Pharmaceuticals Company Information
  27. 6.5.2 Galmed Pharmaceuticals Business Overview
  28. 6.5.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
  30. 6.5.5 Galmed Pharmaceuticals Recent Developments
  31. 6.6 Genfit
  32. 6.6.1 Genfit Company Information
  33. 6.6.2 Genfit Business Overview
  34. 6.6.3 Genfit Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Genfit Nonalcoholic Steatohepatitis Treatment Product Portfolio
  36. 6.6.5 Genfit Recent Developments
  37. 6.7 Gilead
  38. 6.7.1 Gilead Company Information
  39. 6.7.2 Gilead Business Overview
  40. 6.7.3 Gilead Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Gilead Nonalcoholic Steatohepatitis Treatment Product Portfolio
  42. 6.7.5 Gilead Recent Developments
  43. 6.8 Novo Nordisk
  44. 6.8.1 Novo Nordisk Company Information
  45. 6.8.2 Novo Nordisk Business Overview
  46. 6.8.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Portfolio
  48. 6.8.5 Novo Nordisk Recent Developments
  49. 6.9 Vivus
  50. 6.9.1 Vivus Company Information
  51. 6.9.2 Vivus Business Overview
  52. 6.9.3 Vivus Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Vivus Nonalcoholic Steatohepatitis Treatment Product Portfolio
  54. 6.9.5 Vivus Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 GSK
  62. 6.11.1 GSK Company Information
  63. 6.11.2 GSK Business Overview
  64. 6.11.3 GSK Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 GSK Nonalcoholic Steatohepatitis Treatment Product Portfolio
  66. 6.11.5 GSK Recent Developments
  67. 6.12 Roche
  68. 6.12.1 Roche Company Information
  69. 6.12.2 Roche Business Overview
  70. 6.12.3 Roche Nonalcoholic Steatohepatitis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Roche Nonalcoholic Steatohepatitis Treatment Product Portfolio
  72. 6.12.5 Roche Recent Developments
7 North America
  1. 7.1 North America Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032)
  2. 7.2 North America Nonalcoholic Steatohepatitis Treatment Market Size by Type
  3. 7.2.1 North America Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Nonalcoholic Steatohepatitis Treatment Market Size by Application
  7. 7.3.1 North America Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country
  11. 7.4.1 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032)
  2. 8.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Type
  3. 8.2.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Application
  7. 8.3.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country
  11. 8.4.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032)
  2. 9.2 China Nonalcoholic Steatohepatitis Treatment Market Size by Type
  3. 9.2.1 China Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032)
  6. 9.3 China Nonalcoholic Steatohepatitis Treatment Market Size by Application
  7. 9.3.1 China Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032)
  2. 10.2 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Type
  3. 10.2.1 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Application
  7. 10.3.1 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country
  11. 10.4.1 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nonalcoholic Steatohepatitis Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst